Literature DB >> 24354596

Fucoidan promotes early step of cardiac differentiation from human embryonic stem cells and long-term maintenance of beating areas.

Sofiane Hamidi1, Didier Letourneur, Rachida Aid-Launais, Antonio Di Stefano, William Vainchenker, Françoise Norol, Catherine Le Visage.   

Abstract

Somatic stem cells require specific niches and three-dimensional scaffolds provide ways to mimic this microenvironment. Here, we studied a scaffold based on Fucoidan, a sulfated polysaccharide known to influence morphogen gradients during embryonic development, to support human embryonic stem cells (hESCs) differentiation toward the cardiac lineage. A macroporous (pore 200 μm) Fucoidan scaffold was selected to support hESCs attachment and proliferation. Using a protocol based on the cardiogenic morphogen bone morphogenic protein 2 (BMP2) and transforming growth factor (TGFβ) followed by tumor necrosis factor (TNFα), an effector of cardiopoietic priming, we examined the cardiac differentiation in the scaffold compared to culture dishes and embryoid bodies (EBs). At day 8, Fucoidan scaffolds supported a significantly higher expression of the 3 genes encoding for transcription factors marking the early step of embryonic cardiac differentiation NKX2.5 (p<0.05), MEF2C (p<0.01), and GATA4 (p<0.01), confirmed by flow cytometry analysis for MEF2C and NKX2.5. The ability of Fucoidan scaffolds to locally concentrate and slowly release TGFβ and TNFα was confirmed by Luminex technology. We also found that Fucoidan scaffolds supported the late stage of embryonic cardiac differentiation marked by a significantly higher atrial natriuretic factor (ANF) expression (p<0.001), although only rare beating areas were observed. We postulated that absence of mechanical stress in the soft hydrogel impaired sarcomere formation, as confirmed by molecular analysis of the cardiac muscle myosin MYH6 and immunohistological staining of sarcomeric α-actinin. Nevertheless, Fucoidan scaffolds contributed to the development of thin filaments connecting beating areas through promotion of smooth muscle cells, thus enabling maintenance of beating areas for up to 6 months. In conclusion, Fucoidan scaffolds appear as a very promising biomaterial to control cardiac differentiation from hESCs that could be further combined with mechanical stress to promote sarcomere formation at terminal stages of differentiation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24354596      PMCID: PMC3993066          DOI: 10.1089/ten.TEA.2013.0149

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  48 in total

1.  Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.

Authors:  P Religa; M Kazi; J Thyberg; Z Gaciong; J Swedenborg; U Hedin
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-11       Impact factor: 7.069

Review 2.  Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches.

Authors:  Andrew K Powell; Edwin A Yates; David G Fernig; Jeremy E Turnbull
Journal:  Glycobiology       Date:  2004-01-12       Impact factor: 4.313

Review 3.  Control of self-renewal and differentiation of hematopoietic stem cells: HOXB4 on the threshold.

Authors:  Hannes Klump; Bernhard Schiedlmeier; Christopher Baum
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

4.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes.

Authors:  I Kehat; D Kenyagin-Karsenti; M Snir; H Segev; M Amit; A Gepstein; E Livne; O Binah; J Itskovitz-Eldor; L Gepstein
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

5.  Low molecular weight fucoidan prevents neointimal hyperplasia in rabbit iliac artery in-stent restenosis model.

Authors:  Jean-François Deux; Anne Meddahi-Pellé; Alain F Le Blanche; Laurent J Feldman; Sylvia Colliec-Jouault; Françoise Brée; Frank Boudghène; Jean-Baptiste Michel; Didier Letourneur
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

6.  Distinctive expression patterns of heparan sulfate O-sulfotransferases and regional differences in heparan sulfate structure in chick limb buds.

Authors:  Ken Nogami; Hiroaki Suzuki; Hiroko Habuchi; Naoki Ishiguro; Hisashi Iwata; Koji Kimata
Journal:  J Biol Chem       Date:  2003-12-03       Impact factor: 5.157

7.  Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds.

Authors:  Shulamit Levenberg; Ngan F Huang; Erin Lavik; Arlin B Rogers; Joseph Itskovitz-Eldor; Robert Langer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-15       Impact factor: 11.205

8.  Transgenic analysis of the atrialnatriuretic factor (ANF) promoter: Nkx2-5 and GATA-4 binding sites are required for atrial specific expression of ANF.

Authors:  Eric M Small; Paul A Krieg
Journal:  Dev Biol       Date:  2003-09-01       Impact factor: 3.582

9.  Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.

Authors:  Satoko Ashikari-Hada; Hiroko Habuchi; Yutaka Kariya; Nobuyuki Itoh; A Hari Reddi; Koji Kimata
Journal:  J Biol Chem       Date:  2004-01-05       Impact factor: 5.157

10.  Protection of transforming growth factor-beta 1 activity by heparin and fucoidan.

Authors:  T A McCaffrey; D J Falcone; D Vicente; B Du; S Consigli; W Borth
Journal:  J Cell Physiol       Date:  1994-04       Impact factor: 6.384

View more
  10 in total

Review 1.  Cardiovascular Bio-Engineering: Current State of the Art.

Authors:  Teresa Simon-Yarza; Isabelle Bataille; Didier Letourneur
Journal:  J Cardiovasc Transl Res       Date:  2017-03-06       Impact factor: 4.132

2.  Effect of cross-linking on the physicochemical and in vitro properties of pullulan/dextran microbeads.

Authors:  Soraya Lanouar; Rachida Aid-Launais; Ana Oliveira; Laurent Bidault; Brigitte Closs; Marie-Noëlle Labour; Didier Letourneur
Journal:  J Mater Sci Mater Med       Date:  2018-05-29       Impact factor: 3.896

3.  Recent Advances in Clinical Translation of Intra-Articular Osteoarthritis Drug Delivery Systems.

Authors:  Carlisle R DeJulius; Shubham Gulati; Karen A Hasty; Leslie J Crofford; Craig L Duvall
Journal:  Adv Ther (Weinh)       Date:  2020-09-28

4.  Fucoidan Modulated Oxidative Stress and Caspase-3 mRNA Expression Induced by Sulfoxaflor in the Brain of Mice.

Authors:  Petek Piner Benli; Merve Kaya; Cagil Coskun
Journal:  Neurotox Res       Date:  2021-09-27       Impact factor: 3.911

5.  Three-Dimensional Environment Sustains Hematopoietic Stem Cell Differentiation into Platelet-Producing Megakaryocytes.

Authors:  Audrey Pietrzyk-Nivau; Sonia Poirault-Chassac; Sophie Gandrille; Sidi-Mohammed Derkaoui; Alexandre Kauskot; Didier Letourneur; Catherine Le Visage; Dominique Baruch
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

Review 6.  New Trends in Heart Regeneration: A Review.

Authors:  Andrei Kochegarov; Larry F Lemanski
Journal:  J Stem Cells Regen Med       Date:  2016-11-29

7.  Calcium-phosphate ceramics and polysaccharide-based hydrogel scaffolds combined with mesenchymal stem cell differently support bone repair in rats.

Authors:  Sophie Frasca; Françoise Norol; Catherine Le Visage; Jean-Marc Collombet; Didier Letourneur; Xavier Holy; Elhadi Sari Ali
Journal:  J Mater Sci Mater Med       Date:  2017-01-21       Impact factor: 3.896

Review 8.  Therapies from Fucoidan: An Update.

Authors:  Janet Helen Fitton; Damien N Stringer; Samuel S Karpiniec
Journal:  Mar Drugs       Date:  2015-09-16       Impact factor: 5.118

Review 9.  Stem Cell-Derived Exosome in Cardiovascular Diseases: Macro Roles of Micro Particles.

Authors:  Ye Yuan; Weijie Du; Jiaqi Liu; Wenya Ma; Lai Zhang; Zhimin Du; Benzhi Cai
Journal:  Front Pharmacol       Date:  2018-05-31       Impact factor: 5.810

10.  Exosomes derived from mesenchymal stem cells inhibit neointimal hyperplasia by activating the Erk1/2 signalling pathway in rats.

Authors:  Zhihui Liu; Chao Wu; Xinliang Zou; Weiming Shen; Jiacai Yang; Xiaorong Zhang; Xiaohong Hu; Haidong Wang; Yi Liao; Tao Jing
Journal:  Stem Cell Res Ther       Date:  2020-06-08       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.